Tilray (NASDAQ:TLRY) Stock Price Up 3.8%

Tilray Inc (NASDAQ:TLRY)’s stock price shot up 3.8% during trading on Thursday . The company traded as high as $1.79 and last traded at $1.79. 11,610,644 shares traded hands during trading, a decline of 60% from the average session volume of 29,361,824 shares. The stock had previously closed at $1.72.

Analysts Set New Price Targets

A number of research firms recently commented on TLRY. Alliance Global Partners upped their price target on shares of Tilray from $2.25 to $2.75 and gave the company a “neutral” rating in a report on Friday, April 5th. CIBC lowered their price target on shares of Tilray from $2.25 to $2.00 and set a “neutral” rating for the company in a report on Wednesday, April 10th. Finally, Canaccord Genuity Group lowered their price target on shares of Tilray from $4.25 to $4.00 and set a “buy” rating for the company in a report on Wednesday, April 10th.

Tilray Stock Up 0.9 %

The company has a current ratio of 1.92, a quick ratio of 1.18 and a debt-to-equity ratio of 0.11. The company has a market capitalization of $1.29 billion, a P/E ratio of -3.95 and a beta of 2.36. The stock’s fifty day moving average is $1.96 and its 200 day moving average is $1.96.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Clear Street Markets LLC bought a new position in Tilray in the 3rd quarter worth $25,000. Macquarie Group Ltd. raised its holdings in Tilray by 188.8% in the 2nd quarter. Macquarie Group Ltd. now owns 8,540 shares of the company’s stock worth $27,000 after purchasing an additional 5,583 shares in the last quarter. Oppenheimer & Co. Inc. bought a new position in Tilray in the 4th quarter worth $27,000. Lake Street Financial LLC bought a new position in Tilray in the 3rd quarter worth $28,000. Finally, Gainplan LLC bought a new position in Tilray in the 4th quarter worth $28,000. 9.35% of the stock is currently owned by institutional investors.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.